SEARCH

SEARCH BY CITATION

References

  • Avet-Loiseau, H., Andree-Ashley, L.E., Moore, D., Mellerin, M.P., Feusner, J., Bataille, R. & Pallavicini, M.G. (1997) Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes, Chromosomes and Cancer, 19, 124133.
  • Cigudosa, J.C., Rao, P.H., Calasanz, M.J., Odero, M.D., Michaeli, J., Jhanwar, S.C. & Chaganti, R.S.K. (1998) Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood, 91, 30073010.
  • Debes-Marun, C.S., Dewald, G.W., Bryant, S., Picken, E., Santana-Dávila, R., González-Paz, N., Winkler, J.M., Kyle, R.A., Gertz, M.A., Witzig, T.E., Dispenzieri, A., Lacy, M.O., Rajkumar, S.V., Lust, J.A., Greipp, P.R. & Fonseca, R. (2003) Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia, 17, 427436.
  • Fonseca, R., Bailey, R.J., Ahmann, G.J., Rajkumar, S.V., Hoyer, J.D., Lust, J.A., Kyle, R.A., Gertz, M.A., Greipp, P.R. & Dewald, G.W. (2002) Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood, 100, 14171424.
  • Fonseca, R., Barlogie, B., Bataille, R., Bastard, C., Bergsagel, P.L., Chesi, M., Davies, F.E., Drach, J., Greipp, P.R., Kirsch, I.R., Kuehl, W.M., Hernández, J.M., Minvielle, S., Pilarski, L.M., Shaughnessy, Jr, J.D., Stewart, A.K. & Avet-Loisseau, H. (2004) Genetics and cytogenetics of multiple myeloma: a Workshop report. Cancer Research, 64, 15461558.
  • Gutiérrez, N.C., Hernández, J.M., García, J.L., Cañizo, M.C., González, M., Hernández, J., González, M.B., García-Marcos, M.A. & San Miguel, J.F. (2001) Differences in genetic changes between multiple myeloma and plasma cell leukemia demostrated by comparative genomic hybridization. Leukemia, 15, 840845.
  • Gutiérrez, N.C., García, J.L., Hernández, J.M., Lumbreras, E., Castellanos, M., Rasillo, A., Mateo, G., Hernández, J.M., Pérez, S., Orfao, A. & San Miguel, J.F. (2004) Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood, 104, 26612666.
  • Kyle, R.A. & Greipp, P.R. (1980) Smoldering multiple myeloma. New England Journal of Medicine, 302, 13471349.
  • Liebisch, P., Viardot, A., Bassermann, N., Wendl, C., Roth, K., Goldschmidt, H., Einsele, H., Straka, C., Stilgenbauer, S., Dohner, H. & Bentz, M. (2003) Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma. British Journal of Haematology, 122, 193201.
  • Nakagawa, Y., Sawanobori, M., Amaya, H., Matsuda, I., Inoue, Y., Suzuki, K., Hashimoto, S. & Kanno, K. (2003) Clinical implications of abnormalities of chromosomes 1 and 13 in multiple myeloma. Acta Haematologica, 109, 129136.
  • Rosiñol, L., Bladé, J., Esteve, J., Aymerich, M., Rozman, M., Montoto, S., Giné, E., Nadal, E., Filella, X., Queralt, R., Carrió, A. & Montserrat, E. (2003) Smoldering multiple myeloma: natural history and recognition of an evolving type. British Journal of Haematology, 123, 631636.
  • Sawyer, J.R., Tricot, G., Mattox, S., Jagannath, S. & Barlogie, B. (1998) Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood, 91, 17321741.